record date: 2080-12-18 renal transplant admit note  12/18/80cause of esrd: dm2, htndate of this kidney transplant: 11.08.80; lurt from step-son; share hla-b and hla-dr; simulect inductioncc:  elevated creatininehpi:   mr. sparks is a 76 y/o m h/o esrd 2/2 dm s/p lurtx 11/08/80 c/b delayed graft function.  pt. had a renal bx on 11/23/80 c/w atn, no acute rejection.  however,  creatinine has failed to fall below 2's despite treatment for uti and hydration.  there has been some question of medication compliance previously, as he frequently confuses his meds.  his fk level has been lowered as a possible source for his allograft dysfunction.  mr. sparks is being admitted for renal transplant biopsy to r/o acute rejection.current immunosuppression: tacrolimus 6mg bid, mmf 750 mg tidother meds: valcyte 450mg qod, bactrim ss 1 qod, diltiazem er 120mg qd, hydralazine 25mg tid, caco3 500mg bid, calcitriol 0.25mcg qd, nexium 40mg qd, flomax 0.8mg qd, insulin nph 6u bid and novolog 5u pre meals, colace qd.pmhx: esrd 2/2 dm and htn x 10years- good urine output prior to transplant. no retinopathy, cad, peripheral neuropathy.-adenomatous polyp : may 2078-gastritis : h. pylori positive-diastolic dysfunction-hyperlipidemia -hyerparathyroidism - pth 367 in nov, 2080-h/o transient ischemic attack 2073-s/p r inguinal hernia repair, 2078-s/p umbilical hernia repair, 2079bkvl neg 11/80exam: gen- wd, wn, m, nadheent- nc, eomi, perla, no lad, opccor- rrr, nml s1s2lungs-cta b/l, no wheezing, no rhonchiabd- s/nt/nd, nabs ext- no leg edemaneuro- a&o x 3today's labs: date/time         na             k              cl             co2            12/18/2080        131 ()        5.2 ()      99             28             12/17/2080        130 ()        4.9           98             26             date/time         bun            cre            egfr           glu            12/18/2080        46 ()            2.2 ()          31 [1]           132 (#)       12/17/2080        41 ()            2.4 ()          28 [2]           298 ()        date/time         anion          12/18/2080        4              12/17/2080        6              date/time         ca             phos           tbili          tp             12/18/2080        9.9                                                         12/17/2080        9.4              2.4                0.8            7.1            date/time         alb            glob           ldh            12/17/2080        3.9               3.2              156            date/time         alt/sgpt       ast/sgot       alkp           tbili          12/17/2080        12                    24                     162 ()           0.8            date/time         ldh            12/17/2080        156            date/time         wbc            rbc            hgb            hct            12/18/2080        4.58           4.02 ()       11.3 ()       34.5 ()       12/17/2080        5.36           4.07 ()       11.0 ()       35.3 ()       date/time         mcv            mch            mchc           plt            12/18/2080        85.7              28.2           32.9                332            12/17/2080        86.8              27.0           31.1 ()           314            date/time         rdw            12/18/2080        13.4           12/17/2080        13.5           date/time         %poly-a        %lymph-a       %mono-a        %eos-a         12/17/2080        72.8                    17.9 ()               7.0                   1.9            date/time         %baso-a        12/17/2080        0.5            date/time         aneut-a        alymp-a        amono-a        aeos-a         12/17/2080        3.91                   .96                   0.38                0.10           date/time         abaso-a        12/17/2080        0.02           date/time         pt             pt-inr         ptt            12/18/2080        13.9           1.1              31.4           date/time         ua-color       ua-gluc        ua-bili        ua-ket         12/17/2080        yellow [3]        neg               neg            neg            date/time         ua-spgr        ua-bld         ua-ph          ua-prot        12/17/2080        1.015                 neg             5.0                neg            date/time         ua-urobi       ua-nit         ua-wbc         mic-sed        12/17/2080        neg                  neg            tr ()                neg            date/time         ocast          hcast          uas-rbc        uas-wbc        12/17/2080        neg                    0                   1                      5 ()           date/time         uas-bact       uas-sqhi       uas-crys       12/17/2080        neg                     tr                 neg            date/time         ua-epis        12/17/2080        neg            date/time         tacro          12/17/2080        7.3 (c)[4]     a/p:mr. sparks is a 76 y/o m h/o esrd 2/2 dm s/p lurtx 11/08/80 c/b delayed graft function.  he will be admitted to the internal medicine under attending harold crosby, m.d. for renal transplant biopsy.1. renal - slightly impaired graft function, probaly due to a combination of bph  vs. increased sensitivity to fk vs. acute rejection . plan for renal transplant bx this afternoon if possible, if not possible will do first thing in the am.2. immunosuppression- cont. current regimen for now, pending renal bx3. cvs- well controlled, however would d/c diltiazem and hydralazine given renal insufficiency.  would start labetolol 200mg tid.4. id- no concerns, u/a negative5. heme- hct stable, inr 1.1, will send off type and hold for biopsy.6. labs- cbc w/diff, bmp, ldh, po4, albumin, tacrolimus level qam._________________________________________yuna k. tripp,pa-cbb#62803patient seen and examined with renal pa i agree with the review of patient problems, history, medication, physical examination, assessment and plan as detailed in the pa note above. followup clinic visit arranged with patient. case was discussed with patient, renal transplant nurse, and pharmacist.harold k. crosby, m.d.